Vision for Europe:Innovation, Investment, Excellence | Yordan Aleksandrov, Pfizer 21/09/2022 Share Alexandra Simionca Related posts11/04/2024Revision of the EU General Pharmaceutical Legislation: more of a compromise than a robust view on the future of biotech innovation in EuropeRead more09/04/2024Life science industry concerns over the workability of EU HTA: Europe cannot miss out on the opportunity to speed up access to innovative medicines for European patientsRead more05/04/2024Syensqo joins EuropaBio: Accelerating Innovation in BiotechnologyRead more